Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic

Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic

The coronavirus illness 2019 (COVID–19) pandemic has triggered a number of hypotheses relating to use of particular medicines and danger of an infection in addition to prognosis. Under these distinctive circumstances, fast solutions require fast engagement in knowledge assortment and analyses, nevertheless, acceptable design and conduct of pharmacoepidemiologic research is required to generate legitimate and dependable …

Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic Read More »